Brief: Immunology Data Shows INOVIO's INO-3107 Induced Expansion Of New Clonal T Cells That Infiltrate Airway Tissue And Correspond With Reduction Of Surgeries For RRP Patients Observed In Phase 1/2 Trial
13/11/2024 13:11
Nov 13 (Reuters) - Inovio Pharmaceuticals Inc INO.O :
* IMMUNOLOGY DATA SHOWS INOVIO'S INO-3107 INDUCED EXPANSION
OF NEW
CLONAL T CELLS THAT INFILTRATE AIRWAY TISSUE AND CORRESPOND WITH
REDUCTION OF SURGERIES FOR RRP PATIENTS OBSERVED IN PHASE 1/2
TRIAL
Source text: ID:nPn3QJnkQa
Further company coverage: INO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million